Caplin Point Laboratories, 524742, CAPLIPOINT Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

17,722.13
31.36
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

17,131.27
0.26%
6.10

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

23.29
12.79
9.72

EBITDA CAGR (%)

10 Years
5 Years
3 Years

25.99
14.81
7.99

PAT CAGR (%)

10 Years
5 Years
3 Years

27.90
17.23
12.54

P:E (Median)

8 Years
5 Years
3 Years

20.03
20.89
23.55

P:BV (Average)

8 Years
5 Years
3 Years

5.70
4.47
4.69

EV:EBITDA (Average)

8 Years
5 Years
3 Years

14.85
15.07
16.57

Earnings Forecasts:

(Updated: 16-09-2025)

Description 2024 2025 2026 2027
Adj EPS 70.67 80.95 96.25
P/E Ratio 32.97 28.78 24.21
Revenue 1937.47 2226.6 2610.05
EBITDA 646.93 745.5 891.1
Net Income 536.31 638.6 760.1
ROA 18.16 22.17 23.22
P/B Ratio 6.21 5.03 4.51
ROE 21.07 18.49 18.89
FCFF 291.96 339.65 417.59 2927.06
FCFF Yield 1.82 2.12 2.61 18.28
Net Debt -897.72 1378.8 1182.3
BVPS 375.01 463.15 516.7

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 182.57 185.64 -1.65% 173.61 139.38 24.56% 185.23 132.83 39.45% 207.93 179.22 16.02%
Expenses 95.96 104.26 -7.96% 98.57 81.70 20.65% 107.84 69.51 55.14% 109.77 89.77 22.28%
EBITDA 86.61 81.38 6.43% 75.04 57.68 30.10% 77.39 63.32 22.22% 98.16 89.45 9.74%
EBIDTM 47.44% 43.84% 43.22% 41.38% 41.78% 47.67% 47.21% 49.91%
Other Income 32.03 21.50 48.98% 41.25 36.18 14.01% 28.83 17.90 61.06% 43.01 24.49 75.62%
Interest 0.04 0.02 100.00% 0.04 0.02 100.00% 0.04 0.03 33.33% 0.02 0.02 0.00%
Depreciation 6.14 6.18 -0.65% 6.09 6.93 -12.12% 6.01 6.76 -11.09% 6.49 6.72 -3.42%
PBT 112.46 96.68 16.32% 110.16 86.91 26.75% 100.17 74.43 34.58% 134.66 107.20 25.62%
Tax 26.57 24.14 10.07% 23.66 17.03 38.93% 25.46 18.98 34.14% 28.92 25.10 15.22%
PAT 85.89 72.54 18.40% 86.50 69.88 23.78% 74.71 55.45 34.73% 105.74 82.10 28.79%
PATM 47.05% 39.08% 49.82% 50.14% 40.33% 41.75% 50.85% 45.81%
EPS 11.30 9.54 18.45% 11.38 9.19 23.83% 9.83 7.30 34.66% 13.91 10.80 28.80%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 510.22 458.96 11.17% 502.45 453.22 10.86% 492.96 435.50 13.19% 483.10 410.06 17.81%
Expenses 332.46 307.15 8.24% 334.39 307.99 8.57% 330.67 293.22 12.77% 318.34 272.66 16.75%
EBITDA 177.76 151.81 17.09% 168.06 145.23 15.72% 162.29 142.28 14.06% 164.76 137.40 19.91%
EBIDTM 34.84% 33.08% 33.45% 32.04% 32.92% 32.67% 34.10% 33.51%
Other Income 23.14 18.56 24.68% 25.74 17.29 48.87% 31.36 17.18 82.54% 20.77 20.43 1.66%
Interest 0.18 0.05 260.00% 0.17 0.15 13.33% 0.18 0.17 5.88% 0.21 0.18 16.67%
Depreciation 16.29 15.96 2.07% 17.04 16.40 3.90% 16.20 13.90 16.55% 16.76 11.76 42.52%
PBT 184.43 154.36 19.48% 176.59 145.97 20.98% 177.27 145.39 21.93% 168.56 145.89 15.54%
Tax 33.70 29.46 14.39% 31.39 24.80 26.57% 37.19 25.59 45.33% 37.65 29.86 26.09%
PAT 150.73 124.90 20.68% 145.20 121.17 19.83% 140.08 119.80 16.93% 130.91 116.03 12.82%
PATM 29.54% 27.21% 28.90% 26.74% 28.42% 27.51% 27.10% 28.30%
EPS 20.11 16.31 23.30% 18.76 16.01 17.18% 18.28 15.43 18.47% 17.21 15.12 13.82%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 749.34 752.41 625.09 528.61 528.06 482.68 527.83 536.91 426.57 341.55 231.29 Net Sales Growth 17.62% 20.37% 18.25% 0.10% 9.40% -8.55% -1.69% 25.87% 24.89% 47.67% Cost Of Goods Sold 235.87 238.17 205.22 198.06 204.65 194.83 238.18 237.03 180.11 161.94 116.73 Gross Profit 513.47 514.24 419.87 330.55 323.41 287.85 289.65 299.87 246.46 179.61 114.56 GP Margin 68.52% 68.35% 67.17% 62.53% 61.24% 59.64% 54.88% 55.85% 57.78% 52.59% 49.53% Total Expenditure 412.14 420.44 338.01 309.23 308.58 273.14 320.83 348.31 284.33 247.72 168.78 Power & Fuel Cost - 14.11 15.43 9.89 9.54 6.36 7.19 12.29 10.96 9.85 7.55 % Of Sales - 1.88% 2.47% 1.87% 1.81% 1.32% 1.36% 2.29% 2.57% 2.88% 3.26% Employee Cost - 51.56 37.18 35.81 29.91 26.03 24.39 40.49 37.29 29.48 17.58 % Of Sales - 6.85% 5.95% 6.77% 5.66% 5.39% 4.62% 7.54% 8.74% 8.63% 7.60% Manufacturing Exp. - 63.82 54.17 42.18 34.68 27.15 33.34 38.72 37.02 28.34 13.84 % Of Sales - 8.48% 8.67% 7.98% 6.57% 5.62% 6.32% 7.21% 8.68% 8.30% 5.98% General & Admin Exp. - 22.48 18.24 13.52 12.55 6.50 8.55 14.96 12.18 12.63 7.60 % Of Sales - 2.99% 2.92% 2.56% 2.38% 1.35% 1.62% 2.79% 2.86% 3.70% 3.29% Selling & Distn. Exp. - 20.07 1.88 3.91 12.23 2.78 5.89 2.64 4.74 5.37 2.11 % Of Sales - 2.67% 0.30% 0.74% 2.32% 0.58% 1.12% 0.49% 1.11% 1.57% 0.91% Miscellaneous Exp. - 10.23 5.89 5.86 5.02 9.49 3.29 2.17 2.03 0.11 2.11 % Of Sales - 1.36% 0.94% 1.11% 0.95% 1.97% 0.62% 0.40% 0.48% 0.03% 1.46% EBITDA 337.20 331.97 287.08 219.38 219.48 209.54 207.00 188.60 142.24 93.83 62.51 EBITDA Margin 45.00% 44.12% 45.93% 41.50% 41.56% 43.41% 39.22% 35.13% 33.35% 27.47% 27.03% Other Income 145.12 134.59 105.84 99.54 56.69 23.01 65.97 35.40 23.31 12.51 3.47 Interest 0.14 0.12 0.10 0.12 0.09 0.17 0.19 0.50 0.52 0.50 0.31 Depreciation 24.73 24.77 27.08 25.65 25.77 22.44 19.65 20.84 18.99 13.26 7.30 PBT 457.45 441.67 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 Tax 104.61 102.18 82.03 58.89 62.44 53.71 55.49 54.49 43.74 22.26 13.05 Tax Rate 22.87% 23.13% 22.43% 20.09% 24.95% 25.58% 21.92% 26.89% 29.95% 24.04% 22.35% PAT 352.84 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 PAT before Minority Interest 352.84 339.49 283.71 234.26 187.87 156.23 197.64 148.17 102.31 70.32 45.33 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 47.09% 45.12% 45.39% 44.32% 35.58% 32.37% 37.44% 27.60% 23.98% 20.59% 19.60% PAT Growth 26.03% 19.66% 21.11% 24.69% 20.25% -20.95% 33.39% 44.82% 45.49% 55.13% EPS 46.43 44.67 37.33 30.82 24.72 20.56 26.01 19.50 13.46 9.25 5.96

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 1,988.73 1,937.47 1,694.10 1,466.73 1,269.41 1,061.29 863.20 648.69 539.84 401.65 238.72 Net Sales Growth 13.14% 14.37% 15.50% 15.54% 19.61% 22.95% 33.07% 20.16% 34.41% 68.25% Cost Of Goods Sold 780.61 770.84 724.18 663.21 557.51 471.74 413.16 288.78 238.18 184.93 121.16 Gross Profit 1,208.12 1,166.63 969.92 803.52 711.90 589.55 450.04 359.91 301.66 216.72 117.56 GP Margin 60.75% 60.21% 57.25% 54.78% 56.08% 55.55% 52.14% 55.48% 55.88% 53.96% 49.25% Total Expenditure 1,315.86 1,290.54 1,142.66 1,026.21 874.88 737.04 603.13 416.84 344.52 276.84 174.51 Power & Fuel Cost - 37.83 33.57 25.53 21.40 16.36 14.81 13.76 10.98 9.91 7.56 % Of Sales - 1.95% 1.98% 1.74% 1.69% 1.54% 1.72% 2.12% 2.03% 2.47% 3.17% Employee Cost - 177.15 142.66 136.12 114.74 101.97 67.15 45.58 37.61 29.71 17.92 % Of Sales - 9.14% 8.42% 9.28% 9.04% 9.61% 7.78% 7.03% 6.97% 7.40% 7.51% Manufacturing Exp. - 120.13 117.73 90.99 82.01 69.85 68.23 43.49 37.11 28.56 14.33 % Of Sales - 6.20% 6.95% 6.20% 6.46% 6.58% 7.90% 6.70% 6.87% 7.11% 6.00% General & Admin Exp. - 112.05 92.97 85.38 66.68 38.53 25.50 20.82 12.27 13.78 8.15 % Of Sales - 5.78% 5.49% 5.82% 5.25% 3.63% 2.95% 3.21% 2.27% 3.43% 3.41% Selling & Distn. Exp. - 62.25 24.88 18.78 27.52 18.03 9.95 2.08 5.92 9.41 2.29 % Of Sales - 3.21% 1.47% 1.28% 2.17% 1.70% 1.15% 0.32% 1.10% 2.34% 0.96% Miscellaneous Exp. - 10.29 6.67 6.20 5.02 20.56 4.33 2.33 2.45 0.55 2.29 % Of Sales - 0.53% 0.39% 0.42% 0.40% 1.94% 0.50% 0.36% 0.45% 0.14% 1.30% EBITDA 672.87 646.93 551.44 440.52 394.53 324.25 260.07 231.85 195.32 124.81 64.21 EBITDA Margin 33.83% 33.39% 32.55% 30.03% 31.08% 30.55% 30.13% 35.74% 36.18% 31.07% 26.90% Other Income 101.01 96.43 66.94 56.52 38.89 27.93 41.33 19.03 12.67 9.96 3.66 Interest 0.74 0.61 0.78 0.78 0.70 1.59 0.32 0.58 0.61 0.52 0.34 Depreciation 66.29 65.96 53.44 44.99 46.90 36.97 31.62 23.43 19.00 13.30 7.48 PBT 706.85 676.79 564.16 451.27 385.82 313.62 269.46 226.88 188.38 120.95 60.05 Tax 139.93 135.69 103.01 74.36 77.37 62.19 54.38 50.32 43.74 25.44 14.28 Tax Rate 19.80% 20.05% 18.26% 16.48% 20.05% 19.83% 20.18% 22.18% 23.22% 21.03% 23.78% PAT 566.92 536.31 457.09 376.26 299.84 242.27 215.00 176.56 144.78 95.61 45.77 PAT before Minority Interest 565.13 541.09 461.42 376.99 308.45 251.43 215.08 176.56 144.63 95.50 45.77 Minority Interest -1.79 -4.78 -4.33 -0.73 -8.61 -9.16 -0.08 0.00 0.15 0.11 0.00 PAT Margin 28.51% 27.68% 26.98% 25.65% 23.62% 22.83% 24.91% 27.22% 26.82% 23.80% 19.17% PAT Growth 17.64% 17.33% 21.48% 25.49% 23.76% 12.68% 21.77% 21.95% 51.43% 108.89% EPS 74.59 70.57 60.14 49.51 39.45 31.88 28.29 23.23 19.05 12.58 6.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,700.93 1,390.15 1,139.91 930.65 758.67 599.91 432.04 295.60 200.12 128.14 Share Capital 15.20 15.19 15.18 15.16 15.13 15.13 15.13 15.12 15.12 15.11 Total Reserves 1,666.09 1,360.74 1,109.36 900.04 728.75 575.34 410.06 277.19 184.91 111.40 Non-Current Liabilities 13.70 13.29 16.42 24.63 24.99 27.16 24.77 27.86 19.90 13.69 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 0.85 0.43 0.00 0.00 0.00 0.00 0.00 0.00 0.40 1.63 Current Liabilities 99.85 118.87 146.85 98.88 77.33 64.26 82.51 87.34 97.05 120.77 Trade Payables 60.96 78.62 70.63 65.02 70.11 51.41 59.50 72.89 66.01 51.47 Other Current Liabilities 28.21 36.26 65.26 32.66 6.06 11.97 21.76 13.86 29.37 60.37 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 10.68 3.99 10.96 1.20 1.16 0.87 1.25 0.58 1.67 8.92 Total Liabilities 1,814.48 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60 Net Block 205.26 165.79 156.85 162.46 182.68 166.93 137.77 169.32 151.75 142.75 Gross Block 381.41 318.45 285.13 268.64 266.22 228.35 179.85 231.63 195.07 178.70 Accumulated Depreciation 176.15 152.66 128.28 106.18 83.54 61.43 42.08 62.31 43.32 35.94 Non Current Assets 988.79 819.21 641.48 448.49 348.35 310.59 251.37 197.59 180.34 147.78 Capital Work in Progress 20.64 27.75 42.68 2.60 1.36 3.77 8.62 15.29 3.42 0.23 Non Current Investment 491.11 346.17 274.97 212.73 138.64 135.54 98.62 1.87 14.58 1.43 Long Term Loans & Adv. 257.13 272.07 164.70 70.70 5.67 4.36 6.36 11.11 10.59 3.37 Other Non Current Assets 14.65 7.43 2.28 0.00 20.00 0.00 0.00 0.00 0.00 0.00 Current Assets 825.69 703.10 661.70 605.67 512.64 380.74 287.95 213.21 136.73 114.82 Current Investments 311.33 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 Inventories 66.26 86.25 51.53 42.81 24.87 22.37 23.52 28.46 22.29 17.90 Sundry Debtors 175.33 128.67 88.24 53.73 98.46 218.98 125.39 86.35 3.21 6.80 Cash & Bank 214.71 215.78 271.38 316.08 345.49 58.27 44.85 28.28 76.66 64.77 Other Current Assets 58.06 14.68 2.17 11.97 33.28 20.89 24.56 23.78 30.37 25.35 Short Term Loans & Adv. 27.36 19.74 38.20 129.11 14.97 10.57 15.95 17.00 23.05 14.93 Net Current Assets 725.84 584.23 514.85 506.79 435.31 316.48 205.44 125.87 39.67 -5.95 Total Assets 1,814.48 1,522.31 1,303.18 1,054.16 860.99 691.33 539.32 410.80 317.07 262.60

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 2,850.49 2,315.71 1,880.48 1,483.93 1,185.83 947.91 632.91 363.83 224.76 128.14 Share Capital 89.78 89.77 89.76 89.74 89.71 89.71 51.05 15.12 15.12 15.11 Total Reserves 2,741.06 2,211.72 1,775.35 1,378.74 1,081.33 848.76 575.01 345.42 209.56 111.40 Non-Current Liabilities 13.24 7.89 2.13 12.55 17.39 24.86 23.42 27.86 19.90 13.69 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.02 0.29 0.32 0.48 0.73 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 1.74 9.04 7.78 8.48 5.69 5.23 0.13 0.00 0.40 1.63 Current Liabilities 305.99 330.85 268.00 207.68 142.85 144.32 86.11 108.67 113.36 125.04 Trade Payables 217.58 229.62 152.56 155.94 88.50 64.14 60.47 94.23 78.60 55.71 Other Current Liabilities 64.28 90.29 99.94 48.68 51.87 79.28 24.20 13.86 33.09 60.39 Short Term Borrowings 0.55 0.28 3.41 0.50 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 23.58 10.66 12.09 2.56 2.48 0.91 1.44 0.58 1.67 8.94 Total Liabilities 3,205.62 2,685.57 2,177.40 1,730.11 1,363.61 1,125.75 742.52 500.45 358.38 267.14 Net Block 545.78 452.66 279.81 286.57 305.34 272.50 226.84 169.48 151.83 144.23 Gross Block 859.52 702.31 480.32 445.74 422.58 354.79 271.51 231.79 195.15 180.76 Accumulated Depreciation 313.74 249.65 200.51 159.17 117.24 82.29 44.67 62.31 43.31 36.53 Non Current Assets 1,071.67 792.65 625.21 432.29 349.04 303.23 248.83 196.34 179.16 148.61 Capital Work in Progress 143.50 116.62 220.71 17.73 13.88 20.12 9.70 15.29 3.42 0.23 Non Current Investment 279.13 137.63 70.52 37.01 0.66 0.56 0.33 0.33 13.24 0.44 Long Term Loans & Adv. 88.61 78.31 51.51 89.90 7.92 10.05 11.95 11.23 10.67 3.71 Other Non Current Assets 14.65 7.43 2.66 1.08 21.24 0.00 0.00 0.00 0.00 0.00 Current Assets 2,133.95 1,892.92 1,552.19 1,297.82 1,014.57 822.53 493.69 304.11 179.22 118.53 Current Investments 311.33 237.98 210.18 51.97 10.54 60.23 69.62 46.34 4.20 0.00 Inventories 336.10 363.04 288.22 227.31 179.01 238.23 37.45 28.46 22.29 18.81 Sundry Debtors 632.49 542.72 394.06 317.05 279.36 228.96 159.81 125.88 33.02 7.95 Cash & Bank 591.41 552.74 493.48 462.99 438.33 223.43 152.99 79.28 93.07 68.10 Other Current Assets 262.62 50.43 22.82 13.61 107.33 71.68 73.83 24.16 26.63 23.67 Short Term Loans & Adv. 185.51 146.01 143.43 224.89 87.08 56.81 64.61 17.28 19.31 12.58 Net Current Assets 1,827.96 1,562.07 1,284.19 1,090.14 871.72 678.21 407.58 195.44 65.86 -6.51 Total Assets 3,205.62 2,685.57 2,177.40 1,730.11 1,363.61 1,125.76 742.52 500.45 358.38 267.14

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 195.87 111.01 157.10 230.97 294.64 87.01 107.34 22.61 55.49 44.37 PBT 441.67 365.74 293.15 250.31 209.94 253.12 202.65 146.05 92.58 58.38 Adjustment -84.47 -68.57 -59.57 -19.43 7.75 -32.58 -0.29 3.44 8.06 3.89 Changes in Working Capital -57.49 -99.07 -11.45 62.07 131.85 -83.19 -54.17 -92.59 -24.76 -7.20 Cash after chg. in Working capital 299.71 198.10 222.13 292.95 349.54 137.36 148.19 56.90 75.88 55.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -103.84 -87.09 -65.03 -61.98 -54.90 -50.35 -40.84 -34.29 -20.39 -10.69 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -140.20 -118.94 -86.67 -275.93 -3.71 -41.06 -76.51 -59.71 -37.07 -5.98 Net Fixed Assets -55.85 -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 Net Investments -218.29 -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 Others 133.94 -1.55 190.35 -156.75 -14.84 30.12 -14.93 18.15 -0.16 1.67 Cash from Financing Activity -38.10 -34.26 -30.42 -22.76 -3.47 -32.92 -15.21 -11.60 -6.74 -13.95 Net Cash Inflow / Outflow 17.57 -42.19 40.01 -67.72 287.46 13.03 15.62 -48.70 11.67 24.45 Opening Cash & Equivalents 80.64 122.02 81.01 148.82 55.61 42.52 26.18 74.89 63.22 40.32 Closing Cash & Equivalent 99.64 80.64 122.02 81.01 342.88 55.61 42.52 26.18 74.89 64.77

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 432.37 318.39 271.37 336.73 268.61 44.68 83.42 66.49 67.61 42.40 PBT 676.78 564.43 451.35 385.82 313.62 269.46 226.88 188.38 120.95 60.05 Adjustment 5.51 2.40 11.77 30.44 23.09 7.09 19.12 14.84 8.61 3.87 Changes in Working Capital -122.28 -139.44 -103.75 1.96 -1.96 -177.11 -120.06 -100.38 -38.39 -5.13 Cash after chg. in Working capital 560.01 427.39 359.37 418.22 334.75 99.44 125.94 102.84 91.16 58.78 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -127.64 -109.00 -88.00 -81.49 -66.14 -54.76 -42.51 -36.35 -23.55 -16.38 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -334.73 -320.04 -217.58 -376.77 -29.44 -54.50 -100.46 -69.02 -36.11 -5.72 Net Fixed Assets -55.85 -18.39 -56.57 -3.66 -35.46 -43.65 58.45 -48.43 -19.56 -7.66 Net Investments -218.29 -99.00 -220.45 -115.52 46.59 -27.53 -120.03 -29.43 -17.35 0.01 Others -60.59 -202.65 59.44 -257.59 -40.57 16.68 -38.88 8.84 0.80 1.93 Cash from Financing Activity -38.32 -38.07 -28.17 -40.68 -23.98 79.77 89.79 -11.60 -6.74 -13.95 Net Cash Inflow / Outflow 59.32 -39.72 25.62 -80.72 215.19 69.94 72.76 -14.13 24.76 22.73 Opening Cash & Equivalents 138.70 177.56 150.76 231.57 220.77 150.65 77.17 91.31 66.55 45.37 Closing Cash & Equivalent 193.74 134.20 170.92 150.76 435.72 220.77 150.65 77.17 91.31 68.10

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 221.22 181.16 148.16 120.74 98.33 78.06 56.22 38.66 26.47 16.25 ROA 20.35% 20.08% 19.87% 19.62% 20.13% 32.12% 31.19% 28.11% 24.26% 18.66% ROE 22.21% 22.69% 22.97% 22.65% 23.42% 38.92% 41.30% 41.56% 43.57% 42.62% ROCE 28.58% 28.92% 28.33% 29.64% 30.92% 49.05% 55.76% 58.99% 56.89% 53.75% Fixed Asset Turnover 2.15 2.07 1.91 1.97 1.95 2.59 2.61 2.00 1.83 1.45 Receivable days 73.74 63.33 49.01 52.60 120.02 119.07 71.97 38.32 5.35 5.38 Inventory Days 36.99 40.23 32.57 23.39 17.86 15.87 17.67 21.71 21.48 24.11 Payable days 106.95 132.73 124.99 120.50 113.83 61.02 67.67 86.81 85.61 98.57 Cash Conversion Cycle 3.77 -29.17 -43.41 -44.52 24.05 73.91 21.97 -26.78 -58.79 -69.08 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 Interest Cover 3681.58 3658.40 2443.92 2782.22 1235.94 1369.24 404.61 281.22 185.02 190.79

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 362.67 293.21 235.91 183.89 144.94 114.21 78.03 47.69 29.73 16.25 ROA 18.37% 18.98% 19.30% 19.94% 20.20% 23.02% 28.41% 33.68% 30.54% 18.46% ROE 21.72% 22.97% 23.68% 24.77% 25.65% 29.58% 37.14% 49.43% 54.97% 43.13% ROCE 26.22% 26.92% 26.85% 28.77% 28.82% 33.35% 45.59% 64.08% 69.03% 55.41% Fixed Asset Turnover 2.48 2.87 3.17 2.92 2.73 2.76 2.58 2.53 2.14 1.48 Receivable days 110.70 100.92 88.48 85.74 87.41 82.19 80.37 53.72 18.62 10.40 Inventory Days 65.86 70.16 64.15 58.42 71.75 58.28 18.54 17.16 18.68 24.83 Payable days 105.88 96.31 84.89 80.02 59.05 28.33 65.76 89.68 88.17 103.48 Cash Conversion Cycle 70.68 74.76 67.73 64.14 100.11 112.15 33.15 -18.80 -50.88 -68.24 Total Debt/Equity 0.00 0.00 0.00 0.00 0.01 0.04 0.00 0.00 0.00 0.02 Interest Cover 1110.48 724.63 579.65 552.17 198.25 843.86 391.22 309.72 235.08 179.35

Top Investors:

investor education and protection fund (iepf)

uti multi cap fund

llp

Annual Reports:

News Update:

Caplin Point’s arm gets USFDA’s final nod for Milrinone Lactate in 5% Dextrose Injection
3rd Sep 2025, 16:14 PM

Milrinone Lactate in 5% Dextrose Injection had US sales of around $11 million for the 12-month period ending July 2025
Read More
Caplin Point Laboratories reports 23% rise in Q1 consolidated net profit
7th Aug 2025, 15:36 PM

The consolidated total income of the company increased by 11.69% at Rs 533.36 crore for Q1FY26
Read More
Caplin Point Lab - Quarterly Results
7th Aug 2025, 12:54 PM

Read More

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Caplin Point Laboratories Ltd.

Pharmaceuticals & Drugs - Global

BSE: 524742 | NSE: CAPLIPOINT

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: